Insilico Medicine Founder and CEO Alex Zhavoronkov Recognized in Inaugural SCW75 for Pioneering AI-Driven Drug Discovery and Longevity Research (IMAGE)

InSilico Medicine

Insilico Medicine Founder and CEO Alex Zhavoronkov Recognized in Inaugural SCW75 for Pioneering AI-Driven Drug Discovery and Longevity Research

Caption

Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, is proud to announce that its Founder and CEO, Alex Zhavoronkov, has been named to the inaugural SCW75 list by Scientific Computing World. The SCW75 is a new recognition program celebrating the 75 most influential figures driving the transformation of high-performance computing (HPC), AI infrastructure, laboratory informatics, and simulation across the globe.

 

Credit

Insilico Medicine

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.